$ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Data is available to registered users only